Plasma granulysin levels and cellular interferon-γ production correlate with curative host responses in tuberculosis, while plasma interferon-γ levels correlate with tuberculosis disease activity in adults

Tuberculosis

Volumn 87, Issue 4, 2007, Pages 312-321

  Sahiratmadja, E ^a,b   Alisjahbana, B ^c   Buccheri, S ^d   Di Liberto, D ^d   de Boer, T ^a   Adnan, I ^b   van Crevel, R ^e   Klein, M R ^a   van Meijgaarden, K E ^a   Nelwan, R H H ^f   van de Vosse, E ^a   Dieli, F ^d   Ottenhoff, T H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^c PADJADJARAN UNIVERSITY   (Indonesia)

^d UNIVERSITY OF PALERMO   (Italy)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Cellular granulysin; Cellular IFN ; Disease severity; Plasma granulysin; Plasma IFN ; Tuberculosis

Indexed keywords

GAMMA INTERFERON; GRANULYSIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; COURSE EVALUATION; DISEASE ACTIVITY; ENDEMIC DISEASE; FEMALE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INDONESIA; INTERFERON PRODUCTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TUBERCULOSIS, PULMONARY;

EID: 34250627938     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.01.002     Document Type: Article

References (40)

1. van Crevel R., Ottenhoff T.H., and van der Meer J.W. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 15 2 (2002) 294-309
2. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu Rev Immunol 19 (2001) 93-129
3. Ottenhoff T.H., Verreck F.A., Hoeve M.A., and van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis 85 1-2 (2005) 53-64
4. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 6 (1993) 2249-2254
5. van de Vosse E., Hoeve M.A., and Ottenhoff T.H. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 4 12 (2004) 739-749
6. Kaufmann S.H. Cell-mediated immunity: dealing a direct blow to pathogens. Curr Biol 9 3 (1999) R97-R99
7. de Jong R., Altare F., Haagen I.A., Elferink D.G., Boer T., Breda Vriesman P.J., et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280 5368 (1998) 1435-1438
8. van Pinxteren L.A., Cassidy J.P., Smedegaard B.H., Agger E.M., and Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 30 12 (2000) 3689-3698
9. Turner J., and Dockrell H.M. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 87 3 (1996) 339-342
10. Smith S.M., Malin A.S., Pauline T., Lukey, Atkinson S.E., Content J., et al. Characterization of human Mycobacterium bovis bacille Calmette-Guerin-reactive CD8+ T cells. Infect Immun 67 10 (1999) 5223-5230
11. Smith S.M., and Dockrell H.M. Role of CD8 T cells in mycobacterial infections. Immunol Cell Biol 78 4 (2000) 325-333
12. Carranza C., Juarez E., Torres M., Ellner J.J., Sada E., and Schwander S.K. Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts. Am J Respir Crit Care Med 173 2 (2006) 238-245
13. Geluk A., van Meijgaarden K.E., Franken K.L., Drijfhout J.W., D'Souza S., Necker A., et al. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol 165 11 (2000) 6463-6471
14. Zheng CF, Ma L, Jones GJ, Gill MJ, Krensky AM, Kubes P, Mody CH. Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans and activation of this pathway is defective in HIV patients. Blood 2006.
15. Pena S.V., and Krensky A.M. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol 9 2 (1997) 117-125
16. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282 5386 (1998) 121-125
17. Krensky A.M., and Clayberger C. Granulysin: a novel host defense molecule. Am J Transplant 5 8 (2005) 1789-1792
18. Ogawa K., Takamori Y., Suzuki K., Nagasawa M., Takano S., Kasahara Y., et al. Granulysin in human serum as a marker of cell-mediated immunity. Eur J Immunol 33 7 (2003) 1925-1933
19. Sakai M., Ogawa K., Shiozaki A., Yoneda S., Sasaki Y., Nagata K., et al. Serum granulysin is a marker for Th1 type immunity in pre-eclampsia. Clin Exp Immunol 136 1 (2004) 114-119
20. Qiu C., Saito S., Sakai M., Ogawa K., Nagata K., and Williams M.A. Plasma granulysin concentrations and preeclampsia risk. Clin Biochem 39 10 (2006) 1016-1021
21. Kishi A., Takamori Y., Ogawa K., Takano S., Tomita S., Tanigawa M., et al. Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer. Cancer Immunol Immunother 50 11 (2002) 604-614
22. Nagasawa M., Kawamoto H., Tsuji Y., and Mizutani S. Transient increase of serum granulysin in a stage IVs neuroblastoma patient during spontaneous regression: case report. Int J Hematol 82 5 (2005) 456-457
23. Pages F., Berger A., Camus M., Sanchez-Cabo F., Costes A., Molidor R., et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353 25 (2005) 2654-2666
24. Ochoa M.T., Stenger S., Sieling P.A., Thoma-Uszynski S., Sabet S., Cho S., et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med 7 2 (2001) 174-179
25. Dieli F., Sireci G., Caccamo N., Di Sano C., Titone L., Romano A., et al. Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis. J Infect Dis 186 12 (2002) 1835-1839
26. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report 2005. WHO/HTM/TB/2005.349. Geneva: World Health Organization; 2005.
27. Falk A, O'Connor JB, Pratt PC, Webb WR, Wier JA, and Wolinsky E. Classification of pulmonary tuberculosis. In: Diagnosis standards and classification of tuberculosis, vol. 6, 12th ed. New York: National Tuberculosis and Respiratory Disease Association; 1969. p. 68-76.
28. Hanson D.A., Kaspar A.A., Poulain F.R., and Krensky A.M. Biosynthesis of granulysin, a novel cytolytic molecule. Mol Immunol 36 7 (1999) 413-422
29. Gamen S., Hanson D.A., Kaspar A., Naval J., Krensky A.M., and Anel A. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol 161 4 (1998) 1758-1764
30. Antas P.R., Cardoso F.L., Pereira K.C., Franken K.L., Cunha K.S., Klatser P., et al. T cell immune responses to mycobacterial antigens in Brazilian tuberculosis patients and controls. Trans R Soc Trop Med Hyg 99 9 (2005) 699-707
31. Stenger S., Mazzaccaro R.J., Uyemura K., Cho S., Barnes P.F., Rosat J.P., et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276 5319 (1997) 1684-1687
32. Clayberger C., and Krensky A.M. Granulysin. Curr Opin Immunol 15 5 (2003) 560-565
33. Sarwal M.M., Jani A., Chang S., Huie P., Wang Z., Salvatierra Jr. O., et al. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol 62 1 (2001) 21-31
34. Stenger S., Rosat J.P., Bloom B.R., Krensky A.M., and Modlin R.L. Granulysin: a lethal weapon of cytolytic T cells. Immunol Today 20 9 (1999) 390-394
35. Sun Q., Burton R.L., and Lucas K.G. Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures. Blood 99 9 (2002) 3302-3309
36. Dieli F., Singh M., Spallek R., Romano A., Titone L., Sireci G., et al. Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy. Scand J Immunol 52 1 (2000) 96-102
37. Barnes P.F., Lu S., Abrams J.S., Wang E., Yamamura M., and Modlin R.L. Cytokine production at the site of disease in human tuberculosis. Infect Immun 61 8 (1993) 3482-3489
38. Verbon A., Juffermans N., Van Deventer S.J., Speelman P., Van Deutekom H., and Van Der P.T. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol 115 1 (1999) 110-113
39. Morosini M., Meloni F., Marone B.A., Paschetto E., Uccelli M., Pozzi E., et al. The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis 7 10 (2003) 994-1000
40. Nagasawa M., Isoda T., Itoh S., Kajiwara M., Morio T., Shimizu N., et al. Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction. Am J Hematol 81 5 (2006) 340-348